Agape ATP (ATPC) Stock Price, News & Analysis

Company Overview

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Key Stats

• Today's Range: $2.72 to $2.94
• 50-Day Range: $1.83 to $5.65
• 52-Week Range: $1.72 to $119.00
• Volume: 29,235 shs
• Average Volume: 46,843 shs
• Market Capitalization: $2.72 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Agape ATP Stock Analysis - MarketRank™

Agape ATP scored higher than 10% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

Agape ATP has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Agape ATP has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Agape ATP is -0.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Agape ATP is -0.19, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Agape ATP has a P/B Ratio of 0.12. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.70% of the float of Agape ATP has been sold short.

Short Interest Ratio / Days to Cover

Agape ATP has a short interest ratio ("days to cover") of 0.07, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Agape ATP has recently decreased by 78.64%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Agape ATP does not currently pay a dividend.

Dividend Growth

Agape ATP does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

MarketBeat Follows

2 people have added Agape ATP to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Agape ATP insiders have not sold or bought any company stock.

Percentage Held by Insiders

2.04% of the stock of Agape ATP is held by insiders.

Percentage Held by Institutions

0.01% of the stock of Agape ATP is held by institutions.

ATPC Stock Analysis - Frequently Asked Questions

How have ATPC shares performed this year?

Agape ATP's stock was trading at $5.3250 at the start of the year. Since then, ATPC stock has decreased by 48.9% and is now trading at $2.72.

How were Agape ATP's earnings last quarter?

Agape ATP Corporation (NASDAQ:ATPC) posted its earnings results on Monday, April, 13th. The company reported ($0.35) earnings per share for the quarter. The firm had revenue of $0.40 million for the quarter. Agape ATP had a negative trailing twelve-month return on equity of 9.91% and a negative net margin of 149.90%.

When did Agape ATP's stock split?

Agape ATP shares reverse split before market open on Tuesday, February 10th 2026.The 1-50 reverse split was announced on Friday, February 6th 2026. The number of shares owned by shareholders was adjusted after the closing bell on Monday, February 9th 2026. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

When did Agape ATP IPO?

Agape ATP (ATPC) raised $7 million in an initial public offering on Wednesday, October 11th 2023. The company issued 1,700,000 shares at $4.00 per share. Network 1 Financial Securities acted as the underwriter for the IPO.

How do I buy shares of Agape ATP?

Shares of ATPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Agape ATP own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Agape ATP investors own include Canoo (GOEV), NVIDIA (NVDA), Plug Power (PLUG), Advanced Micro Devices (AMD), iShares Core S&P 500 ETF (IVV), Mustang Bio (MBIO) and Meta Platforms (META).

Company Calendar

• Last Earnings: 4/13/2026
• Today: 5/06/2026
• Next Earnings (Estimated): 5/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:ATPC
• CIK: 1713210
• Web: www.agapeatpgroup.com
• Phone: (032) 732-5716
• Fax: N/A
• Employees: 40
• Year Founded: 2016

Profitability

• EPS (Trailing Twelve Months): ($14.50)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$2.28 million
• Net Margins: -149.90%
• Pretax Margin: -151.25%
• Return on Equity: -9.91%
• Return on Assets: -9.29%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 11.82
• Quick Ratio: 11.81

Sales & Book Value

• Annual Sales: $1.52 million
• Price / Sales: 1.79
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $22.41 per share
• Price / Book: 0.12

Miscellaneous

• Outstanding Shares: 1,000,000
• Free Float: 981,000
• Market Cap: $2.72 million
• Optionable: Not Optionable
• Beta: -0.92